MyAlcon | South Africa

This page is available in English. Select below for other countries.

Select Another Country

Systane® BALANCE


Key Benefits

Systane® BALANCE is a LONG-LASTING1-3 formula designed for lipid deficient (Evaporative) Dry Eye, especially for MGD sufferers4:

 

  • Restores the lipid layer4
  • Protects against evaporation4
  • Relief from Dry Eye symptoms especially for MGD sufferers4

 

Systane BALANCE pack shot

Features & Technology

 

  • Unique composition with LipiTech™ designed to help rebuild the lipid-layer and stabilize the tear film
  • Exclusive combination of ingredients locks in moisture5
  • Easy dosing due to the handy Drop-Tainer™ bottle

 

Features and Technology

Patient Benefits

 

  • Ideal for long-lasting relief1-3, especially for MGD sufferers1
  • Also suitable for moderate, chronic sufferers*
  • Can use before or after wearing contact lenses**
Smiling gradma and grandkid

*Based on internal assessment and patient segmentation
**Please refer to instructions for use

 

References:

1. Benelli U. Systane lubricant eye drops in the management of ocular dryness. Clin Ophthalmol. 2011:5;783-790.

2. Rangarajan R, Kraybill B, Ogundele A, Ketelson H. Effect of a hyaluronic acid/hydroxypropyl guar artificial tear solution on protection, recovery, and lubricity in models of corneal epithelium. J Ocul Pharmacol Ther. 2015;31(8):491-497.

3. Davitt WF, Bloomenstein M, Christensen M, Martin AE. Efficacy in patients with dry eye after treatment with a new lubricant eye drop formulation. J Ocul Pharmacol Ther. 2010;26(4):347-353.

4. Rolando M, Autori S, Badino F, Barabino S. Protecting the ocular surface and improving the quality of life of dry eye patients: a study of the efficacy of an HP-guar containing ocular lubricant in a population of dry eye patients. J Ocul Pharmacol Ther. 2009;25(3):271-278.

5. Korb DR, Blackie CA, Meadows DL, Christensen M, Tudor M. Evaluation of extended tear stability by two emulsion based artificial tears. Poster presented at: 6th International Conference on the Tear Film and Ocular Surface: Basic Science and Clinical Relevance; September 22-25, 2010; Florence, Italy.